Ben Swann takes a look at the highly unusual timeline by which Moderna Therapeutics is developing its COVID-19 virus vaccine
Now, four scientists with the NIH claim they hold partial patent rights on that vaccine and stand to make up to $150,000 per year.
Meanwhile, as Moderna’s stock price continues to soar, five top executives have sold off $89 million dollars worth of shares, even as the company continues to bypass standard vaccine protocols in the development of its COVID vaccine
Check out http://rt.com
Like us on Facebook http://www.facebook.com/RTnews
Follow us on VK https://vk.com/rt_international
Follow us on Twitter http://twitter.com/RT_com
Follow us on Instagram http://instagram.com/rt
Follow us on Soundcloud https://soundcloud.com/rttv
#RT (Russia Today) is a global #news network broadcasting from Moscow, London, Paris and Washington studios to over 100 countries. RT is the first news channel to break the 1 billion YouTube views benchmark.